Beam Therapeutics' revolutionary gene editing technology could finally find a cure for sickle cell disease. “The stuff we can do now in genome editing would have seemed like magic five or ten years ago,” CEO John Evans said.
Beam Therapeutics' revolutionary gene editing technology could finally find a cure for sickle cell disease. “The stuff we can do now in genome editing would have seemed like magic five or ten years ago,” CEO John Evans said.
No comments:
Post a Comment